Calcium-phosphorus therapy for heart valve disease
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a treatment to lower high calcium and phosphorus levels in your blood, which may slow down calcium buildup in heart valves. It may help people with kidney problems who have valve disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years or older.
- You have heart valve disease with calcium buildup, as shown by an ultrasound or other tests.
- Your kidney function (filtration rate) is below 60 mL/min.
- Your blood phosphorus level is higher than 4.5 mg/dL (1.45 mmol/L).
- You do not have other types of valve disease, such as rheumatic or congenital valve disease.
- You are not scheduled for dialysis within the next 6 months and have no planned heart surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a PCSK9 inhibitor (a cholesterol-lowering medicine) can slow the progression of calcific aortic stenosis, a heart valve condition. It may be an option for people with mild or moderate valve narrowing who are not yet ready for surgery.
This trial tests if a medication called PCSK-9 inhibitor can slow the progression of calcified aortic valve disease, a condition where the heart's aortic valve becomes stiff and narrow. It is for people who also have heart disease or very high cholesterol that hasn't been controlled well with statins.
This trial tests a new drug, JMKX003002, to lower high phosphorus levels in people with end-stage kidney disease who are on hemodialysis. If you have trouble controlling your phosphorus, this treatment might help.
This trial tests if the drug vericiguat can slow down the buildup of calcium in the aortic valve, which causes it to narrow and stiffen. If you have mild-to-moderate aortic valve stenosis and meet the other criteria, this study may help protect your valve from getting worse.
This trial tests whether the blood pressure medication manidipine can slow or reverse calcium buildup in the heart's aortic valve. Researchers are looking for older adults with mild-to-moderate aortic valve narrowing.
This trial studies whether daily folic acid can slow or improve calcific aortic valve disease. It is for people with a mildly to moderately narrowed aortic valve plus calcium seen on a heart CT scan.
Hear when a new Degenerative Heart Valve Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.